Canada's Access to Medicines Regime background
Description
In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems.
Resources
| Name |
Format |
Description |
Link |
| Canada's Access to Medicines Regime background |
HTML |
|
https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/introduction/background.html |
| Canada's Access to Medicines Regime background |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/regime-canadien-acces-medicaments/introduction/contexte.html |